The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...

A new blood test to detect cancer at an early stage has shown promising results, according to a study, as scientists aim to ...

A liquid biopsy is a test to detect or monitor cancer that uses bodily fluids. There are many different types of liquid biopsy. Several are Food and Drug Administration (FDA)-approved, while others ...

The FDA approved the FoundationOne Liquid CDx to identify patients with metastatic non–small cell lung cancer (mNSCLC) with MET exon 14 skipping alterations who may be eligible for tepotinib ...

Prosigna is one of these tests. The Prosigna test uses a specialist machine to look at a sample of cancer tissue that was removed during your surgery. It looks at 50 genes in the cancer cells and how ...

Editorial Note: Forbes Advisor may earn a commission on sales made from partner links on this page, but that doesn't affect our editors' opinions or evaluations. Liquid assets include cash and ...

It follows years of lawsuits against Johnson & Johnson and other companies alleging links between talc-based baby powder and cancer. Despite the lawsuits ... But recent FDA-sponsored testing hasn’t ...

Cancer test results often contain medical terms and abbreviations that may confuse patients. Deciphering these results is a vital step in understanding your diagnosis, determining the cancer stage ...

Biomarker testing — which involves identifying specific aspects of how a cancer behaves — has rapidly become a cornerstone of modern cancer care. By identifying specific genetic, molecular, or protein ...